Cargando…

Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration

In patients with primary canaliculitis, conservative medical therapy is associated with a high recurrence rate. Surgical treatments carry a great resolution rate but sometimes can result in the lacrimal pump dysfunction and canalicular scarring. The aim of this study is to introduce a minimally inva...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jianjiang, Liu, Zuguo, Mashaghi, Alireza, Sun, Xinghuai, Lu, Yi, Li, Yimin, Wu, Dan, Yang, Yujing, Wei, Anji, Zhao, Yujin, Lu, Chun, Hong, Jiaxu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616879/
https://www.ncbi.nlm.nih.gov/pubmed/26426646
http://dx.doi.org/10.1097/MD.0000000000001611
_version_ 1782396734272438272
author Xu, Jianjiang
Liu, Zuguo
Mashaghi, Alireza
Sun, Xinghuai
Lu, Yi
Li, Yimin
Wu, Dan
Yang, Yujing
Wei, Anji
Zhao, Yujin
Lu, Chun
Hong, Jiaxu
author_facet Xu, Jianjiang
Liu, Zuguo
Mashaghi, Alireza
Sun, Xinghuai
Lu, Yi
Li, Yimin
Wu, Dan
Yang, Yujing
Wei, Anji
Zhao, Yujin
Lu, Chun
Hong, Jiaxu
author_sort Xu, Jianjiang
collection PubMed
description In patients with primary canaliculitis, conservative medical therapy is associated with a high recurrence rate. Surgical treatments carry a great resolution rate but sometimes can result in the lacrimal pump dysfunction and canalicular scarring. The aim of this study is to introduce a minimally invasive approach, intracanalicular ophthalmic corticosteroid/antibiotic combination ointment infiltration (IOI, intracanalicular ointment infiltration), and to report our preliminary results for treating primary canaliculitis. In this retrospective, interventional case series, 68 consecutive patients with newly developed primary canaliculitis at a major tertiary eye center between January 2012 and January 2015. Thirty-six patients received conservative medical treatment alone (group 1; 36 eyes). Twenty-two patients and 10 medically uncontrolled patients from group 1 underwent IOI therapy (group 2; 32 eyes). Ten patients and 26 recurrent patients from group 1 and group 2 underwent surgery (group 3; 36 eyes). Patients were followed-up for at least 8 weeks. Clinical characteristics and outcomes were analyzed and compared. In this study, patients’ age, sex, onset location, and durations of disease among 3 groups showed no significant difference. The resolution rate in group 2 was 72.7% (16/22) for new patients and 68.8% (22/32) for gross patients, respectively, both of which are higher than that of group 1 (22.2%, 10/36) but lower than that of group 3 (100%, 36/36). Of group 3, 2 patients received 2 surgical interventions and resolved finally. Microbiological workup was available in 51 patients. The most common isolates were staphylococcus species (27.9%) and streptococcus species (20%). Canalicular laceration developed in 1 patient during the IOI procedure and 1 patient undergoing surgery. Only 2 had postoperative lacrimal pump dysfunction and 1 had canalicular scarring in group 3. The IOI may be an effective and minimally invasive technique for treating primary canaliculitis and obviate the need for further intensive surgery.
format Online
Article
Text
id pubmed-4616879
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-46168792015-10-27 Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration Xu, Jianjiang Liu, Zuguo Mashaghi, Alireza Sun, Xinghuai Lu, Yi Li, Yimin Wu, Dan Yang, Yujing Wei, Anji Zhao, Yujin Lu, Chun Hong, Jiaxu Medicine (Baltimore) 5800 In patients with primary canaliculitis, conservative medical therapy is associated with a high recurrence rate. Surgical treatments carry a great resolution rate but sometimes can result in the lacrimal pump dysfunction and canalicular scarring. The aim of this study is to introduce a minimally invasive approach, intracanalicular ophthalmic corticosteroid/antibiotic combination ointment infiltration (IOI, intracanalicular ointment infiltration), and to report our preliminary results for treating primary canaliculitis. In this retrospective, interventional case series, 68 consecutive patients with newly developed primary canaliculitis at a major tertiary eye center between January 2012 and January 2015. Thirty-six patients received conservative medical treatment alone (group 1; 36 eyes). Twenty-two patients and 10 medically uncontrolled patients from group 1 underwent IOI therapy (group 2; 32 eyes). Ten patients and 26 recurrent patients from group 1 and group 2 underwent surgery (group 3; 36 eyes). Patients were followed-up for at least 8 weeks. Clinical characteristics and outcomes were analyzed and compared. In this study, patients’ age, sex, onset location, and durations of disease among 3 groups showed no significant difference. The resolution rate in group 2 was 72.7% (16/22) for new patients and 68.8% (22/32) for gross patients, respectively, both of which are higher than that of group 1 (22.2%, 10/36) but lower than that of group 3 (100%, 36/36). Of group 3, 2 patients received 2 surgical interventions and resolved finally. Microbiological workup was available in 51 patients. The most common isolates were staphylococcus species (27.9%) and streptococcus species (20%). Canalicular laceration developed in 1 patient during the IOI procedure and 1 patient undergoing surgery. Only 2 had postoperative lacrimal pump dysfunction and 1 had canalicular scarring in group 3. The IOI may be an effective and minimally invasive technique for treating primary canaliculitis and obviate the need for further intensive surgery. Wolters Kluwer Health 2015-10-02 /pmc/articles/PMC4616879/ /pubmed/26426646 http://dx.doi.org/10.1097/MD.0000000000001611 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 5800
Xu, Jianjiang
Liu, Zuguo
Mashaghi, Alireza
Sun, Xinghuai
Lu, Yi
Li, Yimin
Wu, Dan
Yang, Yujing
Wei, Anji
Zhao, Yujin
Lu, Chun
Hong, Jiaxu
Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration
title Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration
title_full Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration
title_fullStr Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration
title_full_unstemmed Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration
title_short Novel Therapy for Primary Canaliculitis: A Pilot Study of Intracanalicular Ophthalmic Corticosteroid/Antibiotic Combination Ointment Infiltration
title_sort novel therapy for primary canaliculitis: a pilot study of intracanalicular ophthalmic corticosteroid/antibiotic combination ointment infiltration
topic 5800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616879/
https://www.ncbi.nlm.nih.gov/pubmed/26426646
http://dx.doi.org/10.1097/MD.0000000000001611
work_keys_str_mv AT xujianjiang noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration
AT liuzuguo noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration
AT mashaghialireza noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration
AT sunxinghuai noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration
AT luyi noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration
AT liyimin noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration
AT wudan noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration
AT yangyujing noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration
AT weianji noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration
AT zhaoyujin noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration
AT luchun noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration
AT hongjiaxu noveltherapyforprimarycanaliculitisapilotstudyofintracanalicularophthalmiccorticosteroidantibioticcombinationointmentinfiltration